A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease

Date
2018
Author
Gül, Ahmet
Batu, Ezgi D.
CANNA, Scott W.
GO, Ellen
HOFFMANN, Patrycja
Leavis, Helen L.
ÖZEN, SEZA
SCHWARTZ, Daniella M.
STONE, Deborah L.
van Royen-Kerkof, Annet
KASTNER, Daniel L.
AKSENTIJEVICH, Ivona
Laxer, Ronald M.
Aeschlimann, Florence A.
Metadata
Show full item record
Abstract
Objectives The association between mutations in TNFAIP3, encoding the NF-kB regulatory protein A20, and a new autoinflammatory disease has recently been recognised. This study aims at describing the clinical phenotypes and disease course of patients with A20 haploinsufficiency (HA20).
URI
http://hdl.handle.net/20.500.12627/78476
https://doi.org/10.1136/annrheumdis-2017-212403
Collections